Ernestina Santos
Overview
Explore the profile of Ernestina Santos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slioui A, Tammam G, Vanoli F, Marina A, Vohanka S, Gilhus N, et al.
Orphanet J Rare Dis
. 2025 Mar;
20(1):115.
PMID: 40069719
Background: Myasthenia gravis (MG) is a rare autoimmune disorder. Several new treatment concepts have emerged in recent years, but access to these treatments varies due to differing national reimbursement regulations,...
2.
Faustino P, Cruz D, Fernandes C, Pereira A, Franco R, Costa S, et al.
Mult Scler Relat Disord
. 2024 Nov;
92:106153.
PMID: 39536620
Introduction: Knowledge about the effect of disease modifying treatment (DMT) in late-onset multiple sclerosis (LOMS, onset ≥50 years-old) is scarce. This study aims to evaluate the association between DMT use...
3.
Moura J, Sambayeta F, Sousa A, Carneiro P, Neves E, Samoes R, et al.
NeuroSci
. 2024 Nov;
5(2):201-208.
PMID: 39483498
Introduction: Anti-GAD65 antibodies are associated with several neurological phenotypes. Antibody titers are increasingly recognized as useful in diagnosis and prognosis. Objective: To describe a Portuguese cohort of patients with anti-GAD65-associated...
4.
Neves A, Cabral A, Serrao C, Oliveira D, Alves J, Alves J, et al.
Mult Scler Relat Disord
. 2024 Oct;
92():105935.
PMID: 39427600
Background: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a heterogeneous entity with either a monophasic or relapsing course. Well-established predictors of relapsing disease are lacking. Objective: Identifying predictors of...
5.
Lopes J, Fonte J, Costa A, Martins D, Samoes R, Sousa A, et al.
Mult Scler Relat Disord
. 2024 Sep;
90():105848.
PMID: 39236487
Background: The coexistence of neuromyelitis optica spectrum disorders (NMOSD) with other autoimmune diseases (AID) has been increasingly reported. The prevalence and significance of this association are not fully understood. Objectives:...
6.
Moura J, Samoes R, Sousa A, Figueiroa S, Mendonca T, Abreu P, et al.
J Neurol Sci
. 2024 Aug;
464:123176.
PMID: 39146881
Introduction: Neuromyelitis optica spectrum disorders (NMOSD) and MOG-associated disease (MOGAD) are an increasingly recognized group of demyelinating disorders of the central nervous system. Previous studies suggest that prognosis is predicted...
7.
Fonseca A, Santos E, Taipa R
J Neuroimmunol
. 2024 May;
392:578370.
PMID: 38797061
Background: Baló's concentric sclerosis (BCS) is a rare variant of multiple sclerosis characterized by unique pathological features of alternating demyelination and preserved myelin. Objectives: To describe two cases of BCS,...
8.
Moura J, Malaquias M, Jorge F, Pinto E, Sardoeira A, Laranjinha I, et al.
Acta Med Port
. 2024 Apr;
37(6):429-435.
PMID: 38669036
Introduction: Neurological involvement in immunoglobulin G4-related disease (IgG4-RD) is increasingly recognized. Its diagnosis can be challenging due to clinical mimics and difficulty in obtaining nervous system biopsies. The aim of...
9.
Moura J, Fernandes J, Lima M, Sousa A, Samoes R, Silva A, et al.
Front Neurol
. 2024 Mar;
15:1277420.
PMID: 38529037
Introduction: Early-onset (EOMG) and late-onset (LOMG) are distinct groups of MG patients. It is unclear if treatment strategies and treatment-related adverse events may differ according to the age of MG...
10.
Moura J, Sousa A, Samoes R, Carneiro P, Neves E, Silva A, et al.
J Thorac Dis
. 2024 Mar;
16(2):973-978.
PMID: 38505076
Background: Anti-titin antibodies have been previously associated with thymoma-associated myasthenia gravis (MG) and a more clinically severe form of MG. While currently only serving as a disease biomarker, its possible...